Overview

Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial

Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
Azithromycin is an antibiotic that is effective against bacteria that been associated with preterm birth (PTB). The purpose of this study is to evaluate if the addition of azithromycin prior to exam indicated cerclage prolongs gestation. A cerclage is a suture placed in the cervix to prolong gestation.
Phase:
Phase 4
Details
Lead Sponsor:
Thomas Jefferson University
Treatments:
Azithromycin
Cefazolin
Indomethacin